Kosteneffektivität von Rivaroxaban nach Hüft- und Kniegelenks-Totalendoprothese aus Krankenversicherungs- und Krankenhaus-Perspektive

Autor: Stollenwerk, B, Zindel, S, Müller, D, Stock, S

Publikováno v: Mainz//2011; 56. Jahrestagung der Deutschen Gesellschaft für Medizinische Informatik, Biometrie und Epidemiologie (gmds), 6. Jahrestagung der Deutschen Gesellschaft für Epidemiologie (DGEpi); 20110926-20110929; Mainz; DOC11gmds001 /20110920/

Einleitung: Nach großen chirurgischen Eingriffen wie Hüftgelenks- oder Kniegelenks-Totalendoprothesen besteht für Patienten ein relativ hohes Risiko für eine venöse Thromboembolie. Um diese zu vermeiden, werden Patienten prophylaktisch mit Antik

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::70eceada41f5cb99585463036899c423

PCV104 - A Societal Perspective Cost-Utility Analysis of Rivaroxaban Compared with Enoxaparin Sodium in Patients Undergoing Total Hip or Total Knee Replacement Surgery

Autor: Stollenwerk, B., Le, L., Zindel, S., Müller, D., Klug, F., Stock, S.

Publikováno v: In Value in Health November 2013 16(7):A530-A530

Structure of the Dispase Autolysis-inducing Protein from Streptomyces mobaraensis and Glutamine Cross-linking Sites for Transglutaminase.

Autor: Fiebig D; Department of Chemical Engineering and Biotechnology, University of Applied Sciences of Darmstadt, 64287 Darmstadt, Germany, and the Department of Chemistry and., Schmelz S; From the Helmholtz-Centre for Infection Research, Braunschweig, 38124 Germany., Zindel S; Department of Chemical Engineering and Biotechnology, University of Applied Sciences of Darmstadt, 64287 Darmstadt, Germany, and the Department of Chemistry and., Ehret V; Department of Chemical Engineering and Biotechnology, University of Applied Sciences of Darmstadt, 64287 Darmstadt, Germany, and., Beck J; Department of Chemical Engineering and Biotechnology, University of Applied Sciences of Darmstadt, 64287 Darmstadt, Germany, and the Department of Chemistry and., Ebenig A; Department of Chemical Engineering and Biotechnology, University of Applied Sciences of Darmstadt, 64287 Darmstadt, Germany, and the Department of Chemistry and., Ehret M; Department of Chemical Engineering and Biotechnology, University of Applied Sciences of Darmstadt, 64287 Darmstadt, Germany, and., Fröls S; Department of Biology, Technische Universität Darmstadt, 64287 Darmstadt, Germany., Pfeifer F; Department of Biology, Technische Universität Darmstadt, 64287 Darmstadt, Germany., Kolmar H; the Department of Chemistry and., Fuchsbauer HL; Department of Chemical Engineering and Biotechnology, University of Applied Sciences of Darmstadt, 64287 Darmstadt, Germany, and hans-lothar.fuchsbauer@h-da.de., Scrima A; From the Helmholtz-Centre for Infection Research, Braunschweig, 38124 Germany, andrea.scrima@helmholtz-hzi.de.

Publikováno v: The Journal of biological chemistry [J Biol Chem] 2016 Sep 23; Vol. 291 (39), pp. 20417-26. Date of Electronic Publication: 2016 Aug 04.

LncRNA MSTRG.22719.16 mediates the reduction of enoxaparin sodium high-viscosity bone cement-induced thrombosis by targeting the ocu-miR-326-5p/CD40 axis.

Autor: Sang, Linchao¹, Ding, Luobin¹, Hao, Kangning¹, Zhang, Ce¹, Shen, Xiaoyu¹, Sun, Hui², Fu, Dehao³ fudehao@sjtu.edu.cn, Qi, Xiangbei¹ qixiangbei163@163.com

Publikováno v: Journal of Orthopaedic Surgery & Research. 9/22/2023, Vol. 18 Issue 1, p1-14. 14p.

A multi-perspective cost-effectiveness analysis comparing rivaroxaban with enoxaparin sodium for thromboprophylaxis after total hip and knee replacement in the German healthcare setting.

Autor: Zindel S; Institute of Health Economics and Clinical Epidemiology of the University of Cologne, Gleueler Strasse 176-178, 50935, Cologne, Germany., Stock S, Müller D, Stollenwerk B

Publikováno v: BMC health services research [BMC Health Serv Res] 2012 Jul 09; Vol. 12, pp. 192. Date of Electronic Publication: 2012 Jul 09.